$CEOS PsyKey Inc. Announces Discussions with Biote
Post# of 720
through its wholly owned subsidiary PsyKey Inc., is pleased to announce it has entered into discussions to establish a strategic partnership with biotechnology company, Zealous Inc.
"Identifying and forming new partnerships is essential to building a solid foundation to expedite the development and launch of PsyKey's unique functional beverage and supplement product offerings," stated Amar Bhatal, President of CeCors, Inc.
Zealous Inc. is a Canadian Biotechnology company whose focus is the development of psilocybin and psilocin, commercially produced using its proprietary bioreactor fermentation technology. Zealous Inc's impressive bioengineering team includes ten PhDs who have a successful track record of producing 99+% pure cytosine, orotate, and beta-nicotinamide mononucleotide on a commercial scale.
https://marketwirenews.com/news-releases/psyk...04353.html